27 mai 2016
Bulletin interne de l'Institut Pasteur
Appels d'offre du 27 mai 2016
- National Institutes of Health (NIH) - Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R01)
Purpose: to support research that will contribute to the overall understanding of Lyme disease and co-infections transmitted by Ixodes ticks. This research opportunity encourages studies that address diverse scientific areas such as 1) pathogenesis, 2) host response, 3) disease transmission, 4) vector biology and natural history, 5) vaccines, 6) diagnostics, and 7) therapeutics.
Budget and duration: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Application due dates: Standard dates apply
Applications can be submitted every February 5th /June 5th/October 5th (R01 due dates) until September 8, 2019
Deadline : plusieurs dates limites : prochaine échéance 05/06/2016
- National Institutes of Health (NIH) - Gene Fusions in Pediatric Sarcomas (R01)
Purpose: to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.
Budget and duration: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Application due dates: Standard dates apply
Applications can be submitted every February 5th /June 5th/October 5th (R01 due dates) until May 8, 2019
Deadline : plusieurs dates limites : prochaine échéance 05/06/2016
- Ambassade de Suède en France et l’Association franco-suédoise pour la recherche (AFSR) - Prix scientifique franco-suédois pour les jeunes chercheurs en France
Objectif : Promouvoir les échanges scientifiques entre la France et la Suède.
Thème de cette année : Vaccination en France et dans le monde et axes suivants :
- Nouvelles stratégies de vaccination (épreuves cliniques incluses)
- Adjuvants immunologiques
- Effets secondaires non-souhaitables de la vaccination
- Interaction entre hôte et agent pathogène
- Stratégies des microbes pour éviter la réponse immunitaire
- Épidémiologie des vaccinations et de l’immunité
Eligibilité : jeunes chercheurs (non suédois), travaillant dans un établissement de recherche en France, durant l’année universitaire 2015 - 2016 et souhaitant établir ou amplifier une collaboration avec un laboratoire suédois.
Deadline : 15/06/2016
- National Institutes of Health (NIH) - Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R21)
Purpose: to support research that will contribute to the overall understanding of Lyme disease and co-infections transmitted by Ixodes ticks. This research opportunity encourages studies that address diverse scientific areas such as 1) pathogenesis, 2) host response, 3) disease transmission, 4) vector biology and natural history, 5) vaccines, 6) diagnostics, and 7) therapeutics.
Budget and duration: The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
Application due dates: Standard dates apply
Applications can be submitted every February 16th /June 16th/October 16th (R21 due dates) until May 8, 2019
Deadline : plusieurs dates limites : prochaine échéance 16/06/2016
- National Institutes of Health (NIH) - Gene Fusions in Pediatric Sarcomas (R21)
Purpose: to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.
Budget and duration: The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in a single year. The maximum project period is 2 years.
Application due dates: Standard dates apply
Applications can be submitted every February 16th /June 16th/October 16th (R21 due dates) until May 8, 2019
Deadline : plusieurs dates limites : prochaine échéance 16/06/2016
- Fondation Médéric Alzheimer - Prix de thèse 2016
Objectif : Ce Prix récompense les titulaires d’une thèse de doctorat en en santé publique, soutenue entre le 15 septembre 2014 et le 31 mai 2016, et portant sur :
- les enjeux de société induits par la maladie d'Alzheimer et les maladies apparentées;
- l’amélioration de la qualité de vie des personnes malades
Deadline : 17/06/2016
- Medicen - Région Paris : Appel à Manifestation d’Intérêts (AMI) - PACIFIC : Physiopathologie, Classification, Innovation dans l’Insuffisance Cardiaque
Objectif : faire émerger et financer des projets collaboratifs public/privé, sur le thème de l’amélioration des connaissances de la physiopathologie, de la nosologie et de l’innovation thérapeutique de l’insuffisance cardiaque chronique.
L’initiative PACIFIC vise à fédérer les compétences académiques, cliniques et industrielles dans des domaines multi-technologiques, en Île-De-France et au niveau national, afin de répondre à des besoins convergents avec des objectifs de valorisation à court et moyen terme (3 à 5 ans) dans des domaines multi-technologiques :
- Amélioration de cohortes cliniques déjà existantes (ex : génotypage, analyse et traitement de données, big/smart data…) ;
- Bio-banques ;
- Phénotypage approfondi :
- Développement de biomarqueurs au sens large (y compris l’imagerie, la génétique, l’expression génique, …) ;
- Monitorage des patients ambulatoires (incluant les technologies de l’information).
L’objet est d’identifier des projets collaboratifs dans 2 thématiques des insuffisances cardiaques :
- 1. Chronique à fraction d’éjection diminuée ;
- 2. Chronique à fraction d’éjection conservée.
Consulter l'appel**
Deadline : 17/06/2016 (19:00)
- National Institutes of Health (NIH) - Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43)
Purpose: to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country.
Broad range of HIV research areas:
- basic, epidemiologic, clinical, behavioral, and social science research across HIV prevention, care and treatment;
- pathophysiology and therapeutics research to address HIV infection,
- research on HIV co-infections, AIDS-defining and HIV-related cancers, neurological and neuro-psychiatric morbidities, and other co-morbidities and health conditions, both infectious and non-infectious,
- bio-statistics for HIV research design and methodology
- bioinformatics, data analysis, data management, data quality assurance and control to support HIV research;
etc...
Budget and duration: Application budgets are limited to $280,000 direct costs per year. The maximum project period is 5 years.
Letter of Intent due dates : 30 days prior to the application due date
Application due dates : August 25, 2016; August 23, 2017; August 23, 2018
Plusieurs dates limites - prochaine échéance 25/07/2016 (Letter of Intent)
- National Institutes of Health (NIH) - Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71)
Purpose: to support research training that strengthens HIV research capacity of institutions in low-and middle-income countries (LMIC). The applications must propose a plan to develop a research training program and the subsequent application that will be submitted in response to the companion D43 FOA (PAR-16-279).
Budget and duration: Application budgets are limited to $28,000 direct costs per year. The maximum project period is 2 years.
Letter of Intent due dates: 30 days prior to the application due date
Application due date: August 25, 2016; August 23, 2017; August 23, 2018
Plusieurs dates limites - prochaine échéance 25/07/2016 (Letter of Intent)
- Fondation ARC - Prix Léopold Griffuel de recherche fondamentale / Prix Léopold Griffuel de recherche translationnelle et clinique
Objectif : récompenser un chercheur dont les travaux ont abouti à une avancée majeure en recherche fondamentale ou en recherche translationnelle et clinique dans le domaine du cancer.
Deadline : 31/07/2016)
- National Institutes of Health (NIH) - Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01)
Purpose: to encourage innovative, high risk, high impact research to investigate the innate and/or adaptive immune responses induced by mycobacterial infections, Bacillus Calmette-Guérin vaccine (BCG) and/or candidate Mycobacterium tuberculosis (Mtb) vaccines in HIV-infected or uninfected individuals. This research is expected to provide data to advance new hypotheses on immune mechanisms that contribute to the advancement of new tuberculosis (TB) vaccines, including in populations also infected with HIV.
Budget and duration: Application budgets are not limited but need to reflect the actual needs of the proposed project. The total project period may not exceed 5 years.
Application due date: September 6, 2016; September 6, 2017; September 6, 2018
Plusieurs dates limites - prochaine échéance 06/09/2016
- UNITAID - Appel à propositions : Faciliter le traitement antituberculeux à titre préventif dans les groupes à haut risque
Objectif : solliciter des propositions pour répondre aux difficultés spécifiques de ce marché, notamment sur les aspects suivants :
- Innovation et disponibilité : des produits nouveaux et/ou supérieurs, adaptés et reposant sur des données probantes, qui pourraient être rapidement introduits sur le marché et mis à la disposition des pays à revenu faible ou intermédiaire de la tranche inférieure.
- Disponibilité à un coût abordable : des technologies ou médicaments nouveaux sont proposés au prix le plus bas possible
- Demande/adoption : les pays, programmes, prestataires et utilisateurs finaux introduisent et adoptent rapidement les nouveaux produits présentant le meilleur rapport coût/efficacité (dans le contexte local).
Si vous avez l’intention de soumettre une proposition, nous vous invitons à remplir le formulaire de soumission et à l’envoyer d’ici le 13 juillet 2016.
A noter : UNITAID a conscience que des essais sont en cours et par conséquent se réserve le droit de modifier son approche pour cet appel à propositions en cas d’évolution de la situation. En outre, UNITAID a conscience de l’importance des efforts déployés actuellement pour diagnostiquer et traiter la tuberculose active, et a l’intention de soutenir les stratégies thérapeutiques préventives qui les complètent.
- National Institutes of Health (NIH) - Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)
Purpose: to encourage research projects that focus on innovative research in the isolation and characterization of exosomes and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer.
Budget and duration: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Letter of Intent due dates: 30 days before the application due date
Application due dates: October 13, 2016; June 13, 2017; October 13, 2017; June 13, 2018; October 15, 2018; June 13, 2019
Deadline : Plusieurs dates limites - prochaine échéance 13/09/2016 (Letter of Intent)
- National Institutes of Health (NIH) - Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21)
Purpose: to encourage research projects that focus on innovative research in the isolation and characterization of exosomes and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer.
Budget and duration: Direct costs are limited to $275,000 over an R21 two-year period
Letter of Intent due dates: 30 days before the application due date
Application due date: October 13, 2016; June 13, 2017; October 13, 2017; June 13, 2018; October 15, 2018; June 13, 2019
Plusieurs dates limites - prochaine échéance 13/09/2016 (Letter of Intent)
- National Institutes of Health (NIH) - Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01)
Purpose: to encourage grant applications that address the long term goal and objective of developing sustained release strategies for HIV treatment or prevention.
Budget and duration: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Application due dates: January 4, 2017; January 4, 2018; January 4, 2019
Deadline : Plusieurs dates limites : prochaine échéance 04/01/2017